Session: Poster and Exhibition Hall Reception Poster Title:PALI-2108, a Colon-Specific PDE4B Inhibitor Prodrug is Activated in the Colon and Reduces Ulcerative Colitis Symptoms in an Acute Colitis DSS ...

A Waterlooville father who lost his wife to bowel cancer after living with colitis for more than half her life, has welcomed ...

Ulcerative colitis (UC) symptoms may include abdominal pain, cramping, and diarrhea. People can experience periods of remission followed by flare-ups, which can lead to treatment changes.

The findings suggest that lipid composition can direct mRNA-based drugs to target organs, such as the intestines, without passing through the liver.

The FDA granted approval to Eli Lilly and Company’s mirikizumab-mrkz (Omvoh) for Crohn disease, expanding its treatment reach ...

The recent U.S. Food and Drug Administration approval for Eli Lilly and Co.'s Omvoh, a new therapy to treat Chron's disease ...

DelveInsight's Inflammatory Bowel disease market Report provides comprehensive insights into the epidemiology and market dynamics across the 7MM. LAS VEGAS , NV, UNITED STATES, January 30, 2025 ...

Piper Sandler analyst maintains an Overweight rating on Teva, citing positive feedback on duvakitug's potential in treating ...

Researchers at Tel Aviv University have achieved a major breakthrough in drug delivery: they have successfully transported lipid nanoparticles encapsulating messenger RNA (mRNA) to the immune system ...

The FDA has accepted Alvotech (ALVO) and Teva's (TEVA) applications for AVT05, their proposed biosimilar to J&J's ...

Groundbreaking new test 90% accurate in finding patients at high risk of bowel cancer - Doctors believe new test could lead ...

EQS-News: ABIVAX / Key word (s): Miscellaneous Abivax Publishes 2025 Financial Calendar 28.01.2025 / 08:30 CET/CEST The issuer is solely responsible for the content of this announcement.